ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article - Wikidata - awgldk - TriplyDB

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

http://www.wikidata.org/entity/Q56986819

about

The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome Optimization of stent deployment by intravascular ultrasound Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough Combining aspirin with antithrombotic agents Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Coronary computed tomography and magnetic resonance imaging Three-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patients.Cost-effectiveness analysis of antithrombotic therapy in nonurgent percutaneous coronary intervention.Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Fondaparinux as a treatment option for heparin-induced thrombocytopenia.Thrombocytopenia following percutaneous coronary intervention.Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation.Antiplatelet and anticoagulant drugs in interventional radiology.The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.Giant thrombus on apical wall of left ventricle due to HIT syndrome after anterior MI.Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease.Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction.Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy Stress testing after percutaneous coronary interventions: a population-based study.Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis.Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.Spectral analysis related to bare-metal and drug-eluting coronary stent implantation.'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.Immediate Postoperative Complications in Patients Undergoing CABG; Investigating the Role of Prior Coronary Stenting A prospective, multicenter, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India.Clinical evidence of interaction between clopidogrel and proton pump inhibitors Primary Percutaneous Coronary Intervention (PPCI) in acute myocardial infarction complicated with cardiogenic shock in a newly emerging cardiac center in Nepal.A cross-sectional study of stand-alone percutaneous coronary intervention in a Nigerian cardiac catheterization laboratory The role of multi-slice computed tomography in stable angina management: a current perspective.Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect.Fractional flow reserve: the past, present and future.

P2860

Q27000201-A71980F7-DF5B-4B38-9623-A348535AD6DA Q27002340-AE17969C-D8A7-4B86-8982-CD080546E74C Q28200611-C90DCBE0-8754-409A-8594-529B3E20EB48 Q28200615-97B1A535-AA21-4FFC-BEEF-D4CA15763E61 Q28219418-807A2980-3B0A-46A1-80D3-22E3C48F0F7F Q30438736-0D4A5B11-855F-44B1-BD1A-415A07B0712D Q30488320-705D3F47-E1F1-4AA2-B3B7-AD5F229C6C6C Q30833808-E5BD212A-A45B-4536-A8F8-880B93C0287C Q33370967-202CFC59-8BD5-4E83-99BC-5E1D4D39E7CB Q33373700-B64FEAEC-5F02-4801-A379-1CCEC7C85A7C Q33375448-7528351F-E529-4C31-B604-9CB80590EE33 Q33387648-9EDCAC1D-1395-47C0-AE36-A4C9682F6E54 Q33394599-09A5F513-6849-40A8-8C5A-E4699CF83B48 Q33395898-25A63ED5-E1BC-48CF-AB92-9C4DA7C14AAE Q33401236-E45DE3EF-B1C5-4F45-97AC-41C7AA6B4A38 Q33409440-C66C6185-4B88-4E8B-A318-69B079322270 Q33687177-2B68B135-E9A0-426D-8C82-1C25B00A5734 Q33749994-573304B8-75E8-423F-920D-6C48142EF36A Q33759974-AA48A699-3910-4FBA-870A-A9B77DCDF15E Q33791290-ACD88069-6608-4721-A23B-4057BF816300 Q33874626-5C6254CD-500D-4586-89D3-62F1B45149D9 Q33934090-F87E5939-E64F-4268-AECF-C829E6B9FFC5 Q34093288-F7431EE0-5471-4F82-8055-12C5B876EBF8 Q34114972-559D763A-6EC2-4082-A134-76E704A37779 Q34135274-81DEAFFA-D452-4989-8F5F-04F177E82F12 Q34174600-C548847F-A8B1-4A73-8DC0-C9A5FD90E4D5 Q34646022-98E9ED16-1A30-4866-925D-9BDAF34A071D Q34771381-72338CBA-06F0-491A-BD38-79835DF90706 Q34793647-9392D9E5-3C5B-416D-BFED-0078A70A304A Q34925593-499A089F-BDA7-4BB0-A338-A6963A2E8B35 Q35028726-CA9D2A1B-EA50-47D9-8BA7-69EEDBBF82E9 Q35033722-850F2EC2-6239-411D-8CCC-970213AB392E Q35084825-52C48BBA-6618-432C-9CC5-290A297FCAF0 Q35085450-B7541947-9D03-42DB-B811-961DE09DFE79 Q35129946-24096C46-B06C-4F17-8AB4-2AB7B8CD3A26 Q35373683-85C231EF-0095-420E-8EC5-5306387B6B87 Q35795759-F0FC719E-350E-4BFE-8F21-15CA12F30515 Q35812673-AEA90E23-45AF-44CE-B80B-4B7786613FE3 Q35834326-3F73E51A-D626-42BD-8494-66D986D0052C Q36131386-462718F4-01E1-4D56-8E23-FC525232D500

P2860

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

http://www.wikidata.org/entity/Q56986819

description

im Januar 2006 veröffentlichter wissenschaftlicher Artikel

@de

наукова стаття, опублікована в січні 2006

@uk

name

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

@en

type

label

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

@en

prefLabel

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

@en

P1433

Q56986819-59010E93-898E-4ADB-BEE6-103CF94DF3BB

P1476

Q56986819-7AADA33D-460C-400C-9802-019BE04F9647

P2093

Q56986819-02BEF8A9-BE01-438B-8B43-36DB520484AD

Q56986819-08168A69-5ABD-460E-AF1E-9C1AB0386CFD

Q56986819-0898A5C2-8375-41B6-99C1-B2B9F72DB8A1

Q56986819-13B0CC79-97F5-4972-8EC6-3869A0EAED63

Q56986819-1604BB17-E643-4D84-91C5-D47FBDD7176F

Q56986819-20CA4806-FB9C-4D15-A83F-9C8F23CDE00C

Q56986819-24373F26-E94F-4C10-BE36-C9F12DBFC06D

Q56986819-28A45E3C-7CBB-40BB-A1EB-D07C056DFE07

Q56986819-32AF6960-EA24-4341-A56F-20F6D3BA9EDE

Q56986819-4B16BC47-CE71-4EC7-85AC-45F264E27A34

P304

Q56986819-37C1B2D6-9062-476A-B8E3-1AD22E998C00

P31

Q56986819-5C105331-F139-47CD-B632-BED7D4FE7C0B

P356

Q56986819-2D90844A-5F3E-4470-B8FA-69A3EB6E658A

P407

Q56986819-9E675C9F-08E5-4F5A-B261-79FC0A3D1A8A

P433

Q56986819-DF340098-12A2-44AD-A2AD-B4F452AFFDA6

P478

Q56986819-5B03B48F-AACE-45AF-A303-4EE81ADCE924

P50

Q56986819-461DDF66-52EE-45AC-9176-0D35189847F4

Q56986819-5398C4F2-B3F5-4AD9-AD58-3644E1142F00

Q56986819-5C19B25D-81D6-4BAD-A28F-285C2C5ED169

Q56986819-A59AB020-2C7F-4182-BD5B-134C366B7495

Q56986819-EC02F97C-D7EC-4D30-80A0-8C0063BE8A96

P577

Q56986819-0DA63A55-BD8D-4F3D-8787-F023B2CEAE42

P698

Q56986819-60E30079-811B-4271-9858-A5DB016266B1

P356

CIRCULATIONAHA.105.170815

P1433

P1476

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

@en

P2093

Alice K. Jacobs

http://www.w3.org/2001/XMLSchema#string

Barbara Riegel

http://www.w3.org/2001/XMLSchema#string

Cynthia D. Adams

http://www.w3.org/2001/XMLSchema#string

David O. Williams

http://www.w3.org/2001/XMLSchema#string

David P. Faxon

http://www.w3.org/2001/XMLSchema#string

Douglass A. Morrison

http://www.w3.org/2001/XMLSchema#string

Hartzell V. Schaff

http://www.w3.org/2001/XMLSchema#string

Jeffrey L. Anderson

http://www.w3.org/2001/XMLSchema#string

John W. Hirshfeld

http://www.w3.org/2001/XMLSchema#string

Joseph P. Ornato

http://www.w3.org/2001/XMLSchema#string

P304

156-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.105.170815

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan L. Halperin

Elliott M Antman

Valentín Fuster Carulla

P577

2006-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16391169

http://www.w3.org/2001/XMLSchema#string